Table 1:
Frequency of Outcomes and Exposures over the Specified Periods
| Period 1 (N=693) | Period 2 (N=639) | Period 3 (N=522) | Period 4 (N=274) | Overall (N=2128) | |
|---|---|---|---|---|---|
| Vaccine Group, N (proportion) | |||||
| Control | 227 (0·33) | 210 (0·33) | 180 (0·34) | 91 (0·34) | 708 (0·33) |
| Three-dose vaccine | 241 (0·35) | 215 (0·34) | 164 (0·31) | 91 (0·33) | 711 (0·33) |
| Four-dose vaccine | 225 (0·32) | 214 (0·33) | 178 (0·34) | 92 (0·33) | 709 (0·33) |
| Bed net use, N (proportion) | |||||
| Yes | 664 (0·96) | 596 (0·93) | 497 (0·95) | 274 (1·00) | 2031 (0·95) |
| No | 29 (0·04) | 43 (0 ·07) | 25 (0·05) | 0 (0·00) | 97 (0·05) |
| Cases / time (days) | 208 / 238,512 | 147 / 166,938 | 192 / 189,396 | 97 / 122,391 | 644 / 717,236 |
| Cases per 18 months | 0·48 | 0·48 | 0·56 | 0·43 | 0·49 |